3 completed, 1 not yet recruiting, 1 terminated, 1 withdrawn. 6 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 3, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow XT-150: new trials by email Literature Review of XT-150 trials Research Report on XT-150
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Study of XT-150 in Participants With ALS XT-150 - Amyotrophic Lateral Sclerosis (ALS) | Phase 1 | Not yet recruiting | Xalud Therapeutics, Inc. | 8 | 2027-03-01 | 2026-07-29 |
| Preliminary Safety and Efficacy of XT-150 in Facet Joint Osteoarthritis XT-150 - Osteoarthritis, Spine | Phase 1 / Phase 2 | Withdrawn | Xalud Therapeutics, Inc. | 2021-10-01 | 2022-03-17 | |
| Safety and Efficacy of XT-150 for Treatment of Neuropathic Pain XT-150, Placebo - Neuropathic Pain | Phase 1 | Terminated | Xalud Therapeutics, Inc. | 5 | 2021-04-14 | 2023-01-23 |
| Follow on Extension of XT-150-1-0201 XT-150 - Osteoarthritis, Knee | Phase 1 | Completed | Xalud Therapeutics, Inc. | 16 | 2019-03-20 | 2020-01-18 |
| Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain XT-150 - Osteoarthritis, Knee | Phase 1 | Completed | Xalud Therapeutics, Inc. | 32 | 2018-06-08 | 2019-11-08 |
| Preliminary Evaluation of Safety, Tolerability, and Efficacy of XT-150 for the Treatment of Osteoarthritic Pain XT-150 - Osteoarthritis, Knee | Phase 1 | Completed | Xalud Therapeutics, Inc. | 24 | 2018-03-21 | 2019-07-05 |
Inflammation (3) · Osteoarthritis, Knee (3) · Pain (2) · Amyotrophic Lateral Sclerosis (1) · Neuralgia (1) · Osteoarthritis (1) · Osteoarthritis, Spine (1)
Australia (4) · United States (2)
Mark Rickman, MD (2) · Howard Rutman, MD,MBA (1) · Stephen Collins, MD, PhD (1)